Naeem Akhtar, MD
Gastroenterology · Madera
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 8
- Since medical school
- 51 years
- Graduated 1975
Offices
8 locations · Community Foundation Medical Group · Central California Faculty Medical Group Inc · Camarena Health
Hospitals listed: Community Regional Medical Center · Saint Agnes Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Akhtar’s office to ask if they take your plan before you enroll.
California Medical Board record
Surgery centers they own
- California Colon and Rectal Cancer Screening Center, LLCAmbulatory Surgery Center · Fresno, CA100% owner since 2009 · accredited by AAAHCAccreditation Renewed2 inspections, 1 with deficiencies · last 2018-01-04: Requirements Met
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Community Regional Medical CenterFresno, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Community Medical Centers, which runs 4 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 1 of 5 starsWorse than the national rate — Death rate among surgical inpatients with serious treatable complications: 211.21 (174.88 to 247.54) · 239 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.705, Oct 2024 – Sep 2025
- Saint Agnes Medical CenterFresno, CAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency department · Birthing-friendlyPart of Trinity Health, which runs 105 hospitals in 16 statesPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.274, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.312, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.141, Oct 2024 – Sep 2025
See every measure and the patient survey for Community Regional Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 1 worse of 8 measures. Safety: 0 better, 7 the same, 0 worse of 7 measures. Readmissions: 0 better, 7 the same, 3 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 211.21 (174.88 to 247.54) · 239 cases | Worse | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.705 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.13 (0.29 to 1.96) · 2,304 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.09 (0.87 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 116 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.7 · 187 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.6 · 445 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.2 · 399 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 582 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 3,744 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.5) · 11,052 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,566 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.33 (1.64 to 5.01) · 3,139 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.08 (0 to 2.3) · 1,423 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.7 (0.52 to 2.88) · 3,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.85 (8.11 to 15.6) · 1,481 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.4 (3.81 to 8.98) · 1,404 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.35 (0.95 to 3.76) · 760 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.64 (0.16 to 1.11) · 10,254 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.817 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.031 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.837 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.81 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.853 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 258 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 689 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 37.4 · 202 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 35.2 · 543 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 39.2 · 434 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.3 · 552 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.6 to 7.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.4 (8.3 to 15.4) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 12.4 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.6 · 248 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.9 (9.5 to 14.9) · 2,590 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 310 cases | No different | Jan 2024 – Dec 2024 |
What patients said (421 patients answered, 26% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 41% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Saint Agnes Medical Center
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 6 the same, 0 worse of 8 measures. Readmissions: 0 better, 6 the same, 3 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.274 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.312 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.141 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.18 to 1.94) · 2,342 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.27) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 197.82 (152.64 to 243.01) · 103 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.9 · 105 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.3 · 300 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.9 · 295 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.8 · 768 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.8 · 969 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.2 · 304 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 4,305 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.06 to 0.42) · 11,641 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.07 to 0.43) · 12,213 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.76 (2.91 to 6.61) · 2,466 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.09 (0 to 2.49) · 864 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.61 (0.26 to 2.96) · 2,362 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.1 (5.39 to 14.81) · 900 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.4 (1.2 to 7.59) · 882 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.84 (0.41 to 3.27) · 541 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.67 (0.14 to 1.19) · 9,626 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 58 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.835 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 1.182 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.004 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 412 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.6 · 1,002 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 28.8 · 296 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 25.5 · 894 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 17.8 · 981 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 1,061 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5 · 56 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 13.4 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 412 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.3 (9.6 to 15.9) · 1,324 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 863 cases | No different | Jan 2024 – Dec 2024 |
What patients said (812 patients answered, 32% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$256,265
Medicare paid this office $256,265 for 1,079 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 763 | $128,065 | $92 |
| New patient visit (45+ min) | 191 | $19,725 | $103 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 220 | $17,756 | $77 |
| Short return visit (20+ min) | 216 | $15,402 | $66 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 84 | $15,173 | $176 |
See all 16 services
| Return visit (30+ min) | 763 | $128,065 | $92 |
| New patient visit (45+ min) | 191 | $19,725 | $103 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 220 | $17,756 | $77 |
| Short return visit (20+ min) | 216 | $15,402 | $66 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 84 | $15,173 | $176 |
| Biopsy of large bowel using a flexible endoscope | 129 | $14,048 | $109 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 58 | $10,361 | $179 |
| Insertion of guide wire with dilation of esophagus using a flexible endoscope | 51 | $5,615 | $106 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 25 | $4,470 | $179 |
| Replacement of stomach stoma tube | 14 | $3,791 | $165 |
| Ultrasound scan of organ tissue for measuring elasticity | 33 | $2,497 | $73 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 26 | $2,188 | $84 |
| New patient visit (30+ min) | 37 | $2,044 | $55 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 412 | $1,852 | $4 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 27 | $1,543 | $57 |
| Injection beneath lining of large bowel using a flexible endoscope | 13 | $172 | $12 |
Procedures Medicare counted
| Colonoscopy | 418 | More than 99% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 406 | More than 98% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 289 | 162 | 247 | 304 | 228 | 230 |
| Biopsy of large bowel using a flexible endoscope | 62 | 37 | 91 | 161 | 160 | 129 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 92 | 51 | 58 | 80 | 95 | 86 |
| Diagnostic exam of large bowel using a flexible endoscope | 88 | 51 | 77 | 89 | 29 | – |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 73 | 50 | 35 | 50 | 63 | 26 |
| Insertion of guide wire with dilation of esophagus using a flexible endoscope | – | 11 | 46 | 70 | 47 | 53 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
1,079 Original Medicare patients in 2024. Average age 71 · Under 65 17% · 85 and older 7% · Women 56% · Also on Medicaid 64% · Health risk score 1.68. Above the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 75% · Diabetes 52% · Chronic kidney disease 33% · Coronary heart disease 31% · Depression 21% · Heart failure 20% · COPD 18% · Atrial fibrillation 14% · Cancer 13% · Stroke 8% · Dementia 7%.
The office billed $1,743,154, Medicare allowed $356,433 and paid $256,265; for 3,122 services of 50 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,079 | 3,122 | 71 | 1.68 | $1,743,154 | $256,265 |
| 2023 | 1,266 | 3,240 | 71 | 1.56 | $1,854,316 | $301,466 |
| 2022 | 1,302 | 3,320 | 70 | 1.44 | $1,038,144 | $331,447 |
| 2021 | 1,257 | 2,885 | 70 | 1.58 | $790,993 | $285,180 |
| 2020 | 1,118 | 2,349 | 70 | 1.75 | $624,214 | $195,994 |
| 2019 | 1,358 | 3,145 | 70 | 1.83 | $955,179 | $323,497 |
| 2018 | 1,237 | 3,256 | 70 | 1.64 | $927,521 | $312,883 |
| 2017 | 1,270 | 3,429 | 70 | 1.59 | $962,987 | $325,933 |
| 2016 | 1,359 | 3,784 | 69 | 1.53 | $1,084,170 | $367,197 |
| 2015 | 1,253 | 3,470 | 70 | 1.62 | $943,520 | $346,029 |
| 2014 | 1,216 | 3,610 | 70 | 1.57 | $985,957 | $368,227 |
| 2013 | 1,286 | 3,931 | 70 | 1.59 | $1,131,363 | $411,336 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 21 services
| Return visit (30+ min) | 707 | $120,421 | $100 |
| New patient visit (45+ min) | 343 | $40,544 | $118 |
| Short return visit (20+ min) | 242 | $19,365 | $71 |
| Biopsy of large bowel using a flexible endoscope | 160 | $18,691 | $117 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 95 | $18,213 | $192 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 219 | $16,039 | $70 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 37 | $6,851 | $185 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 37 | $6,759 | $183 |
| New patient visit (30+ min) | 80 | $5,867 | $73 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 62 | $5,828 | $93 |
| Insertion of guide wire with dilation of esophagus using a flexible endoscope | 45 | $5,170 | $110 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 37 | $5,101 | $131 |
| Diagnostic exam of large bowel using a flexible endoscope | 29 | $3,486 | $120 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 29 | $2,964 | $102 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 44 | $2,926 | $65 |
| Long return visit (40+ min) | 22 | $2,751 | $120 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $1,355 | $65 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 274 | $1,234 | $4 |
| Measurement of liver stiffness | 18 | $444 | $25 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 26 | $238 | $9 |
| Injection beneath lining of large bowel using a flexible endoscope | 11 | $143 | $13 |
2022: 21 services
| Return visit (30+ min) | 641 | $108,769 | $100 |
| New patient visit (45+ min) | 344 | $38,680 | $112 |
| Short return visit (20+ min) | 341 | $28,415 | $71 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 295 | $23,590 | $78 |
| Biopsy of large bowel using a flexible endoscope | 161 | $21,698 | $135 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 109 | $18,035 | $157 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 80 | $16,163 | $202 |
| Diagnostic exam of large bowel using a flexible endoscope | 87 | $12,352 | $139 |
| Insertion of guide wire with dilation of esophagus using a flexible endoscope | 69 | $8,735 | $125 |
| Long return visit (40+ min) | 58 | $8,299 | $138 |
| New patient visit (30+ min) | 113 | $7,740 | $68 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 64 | $5,596 | $56 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 50 | $4,596 | $92 |
| New patient visit (60+ min) | 23 | $3,520 | $153 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 18 | $3,356 | $186 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 15 | $2,585 | $172 |
| Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $1,939 | $162 |
| Insertion of stomach tube using a flexible endoscope | 11 | $1,932 | $161 |
| Measurement of liver stiffness | 51 | $1,247 | $24 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 11 | $874 | $79 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 93 | $415 | $4 |
2021: 21 services
| Return visit (30+ min) | 608 | $86,541 | $88 |
| New patient visit (45+ min) | 352 | $37,336 | $106 |
| Short return visit (20+ min) | 376 | $28,913 | $63 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 236 | $24,004 | $97 |
| Biopsy of large bowel using a flexible endoscope | 91 | $13,368 | $147 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 71 | $11,979 | $158 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 57 | $11,900 | $205 |
| Diagnostic exam of large bowel using a flexible endoscope | 77 | $10,838 | $141 |
| Long return visit (40+ min) | 62 | $7,881 | $119 |
| New patient visit (30+ min) | 104 | $7,269 | $70 |
| Insertion of guide wire with dilation of esophagus using a flexible endoscope | 39 | $6,156 | $134 |
| New patient visit (60+ min) | 30 | $4,683 | $156 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 22 | $4,177 | $190 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 35 | $3,200 | $91 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 12 | $2,276 | $190 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 25 | $2,222 | $54 |
| Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 13 | $2,152 | $166 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 11 | $1,918 | $174 |
| Short return visit | 20 | $755 | $38 |
| Measurement of liver stiffness | 25 | $687 | $27 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 29 | $123 | $4 |
2020: 23 services
| Return visit (30+ min) | 501 | $47,675 | $62 |
| New patient visit (45+ min) | 232 | $21,117 | $91 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 94 | $17,064 | $154 |
| Short return visit (20+ min) | 306 | $15,746 | $42 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 159 | $15,693 | $97 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 51 | $10,033 | $197 |
| Diagnostic exam of large bowel using a flexible endoscope | 51 | $6,830 | $134 |
| Biopsy of large bowel using a flexible endoscope | 37 | $5,634 | $152 |
| New patient visit (30+ min) | 98 | $5,556 | $57 |
| Long return visit (40+ min) | 53 | $5,095 | $91 |
| Destruction of polyp or growth of large bowel using a flexible endoscope | 24 | $5,087 | $212 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 26 | $4,668 | $180 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 36 | $4,425 | $123 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 50 | $3,636 | $73 |
| Insertion of stomach tube using a flexible endoscope | 18 | $3,557 | $169 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 17 | $3,316 | $195 |
| Tying of dilated veins of stomach and/or esophagus using a flexible endoscope | 13 | $2,966 | $198 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 33 | $2,508 | $60 |
| Insertion of guide wire with dilation of esophagus using a flexible endoscope | 11 | $1,480 | $135 |
| Telephone medical discussion with physician, 21-30 minutes | 15 | $1,360 | $91 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,245 | $113 |
| Telephone medical discussion with physician, 5-10 minutes | 24 | $952 | $38 |
| Short return visit | 16 | $416 | $22 |
2019: 20 services
| Return visit (30+ min) | 562 | $76,041 | $83 |
| New patient visit (45+ min) | 313 | $35,903 | $115 |
| Short return visit (20+ min) | 403 | $31,216 | $54 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 278 | $30,560 | $106 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 92 | $18,966 | $206 |
| Diagnostic exam of large bowel using a flexible endoscope | 88 | $12,862 | $146 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 73 | $12,495 | $152 |
| Destruction of polyp or growth of large bowel using a flexible endoscope | 53 | $11,605 | $219 |
| Biopsy of large bowel using a flexible endoscope | 62 | $9,928 | $160 |
| New patient visit (30+ min) | 115 | $8,651 | $75 |
| Long return visit (40+ min) | 75 | $8,542 | $107 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 44 | $8,527 | $194 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 53 | $7,892 | $123 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 72 | $7,017 | $96 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 43 | $4,740 | $110 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 25 | $4,474 | $179 |
| Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | 12 | $3,706 | $285 |
| New patient visit (60+ min) | 19 | $2,947 | $155 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 33 | $2,680 | $81 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 30 | $1,918 | $58 |
2018: 19 services
| Return visit (30+ min) | 525 | $64,783 | $80 |
| Short return visit (20+ min) | 549 | $43,927 | $52 |
| New patient visit (45+ min) | 292 | $32,792 | $112 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 272 | $28,468 | $102 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 109 | $21,687 | $147 |
| Diagnostic exam of large bowel using a flexible endoscope | 118 | $17,260 | $146 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 80 | $15,898 | $196 |
| Destruction of polyp or growth of large bowel using a flexible endoscope | 64 | $13,898 | $217 |
| Biopsy of large bowel using a flexible endoscope | 70 | $10,770 | $154 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 60 | $7,724 | $121 |
| New patient visit (30+ min) | 102 | $7,425 | $73 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 69 | $6,187 | $90 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 35 | $6,010 | $172 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 30 | $5,593 | $186 |
| Long return visit (40+ min) | 46 | $4,613 | $100 |
| Tying of dilated veins of stomach and/or esophagus using a flexible endoscope | 18 | $3,858 | $193 |
| Insertion of stomach tube using a flexible endoscope | 13 | $2,240 | $149 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 29 | $1,944 | $56 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,284 | $107 |
2017: 21 services
| Return visit (30+ min) | 541 | $61,550 | $77 |
| Short return visit (20+ min) | 632 | $52,917 | $52 |
| New patient visit (45+ min) | 297 | $33,217 | $112 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 237 | $25,630 | $104 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 97 | $19,607 | $202 |
| Biopsy of large bowel using a flexible endoscope | 114 | $17,510 | $154 |
| Diagnostic exam of large bowel using a flexible endoscope | 118 | $16,652 | $141 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 90 | $15,042 | $150 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 64 | $10,849 | $170 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 65 | $8,443 | $121 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 43 | $7,945 | $185 |
| New patient visit (30+ min) | 107 | $7,774 | $73 |
| Tying of dilated veins of stomach and/or esophagus using a flexible endoscope | 25 | $5,714 | $190 |
| Long return visit (40+ min) | 56 | $5,571 | $99 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 17 | $4,488 | $264 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 43 | $4,076 | $91 |
| Diagnostic exam of large bowel using a flexible endoscope | 12 | $2,875 | $240 |
| Insertion of stomach tube using a flexible endoscope | 17 | $2,767 | $154 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $1,520 | $56 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,193 | $108 |
| Diagnostic exam of lower portion of large bowel using a flexible endoscope | 11 | $383 | $35 |
2016: 20 services
| Return visit (30+ min) | 549 | $64,450 | $80 |
| Short return visit (20+ min) | 715 | $60,646 | $53 |
| New patient visit (45+ min) | 344 | $38,833 | $113 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 308 | $34,527 | $106 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 105 | $22,085 | $210 |
| Biopsy of large bowel using a flexible endoscope | 126 | $21,140 | $168 |
| Diagnostic exam of large bowel using a flexible endoscope | 115 | $17,616 | $153 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 102 | $15,984 | $148 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 81 | $13,602 | $168 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 65 | $12,630 | $194 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 81 | $10,290 | $124 |
| New patient visit (30+ min) | 113 | $7,904 | $70 |
| Tying of dilated veins of stomach and/or esophagus using a flexible endoscope | 27 | $6,231 | $189 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 59 | $5,976 | $101 |
| Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | 16 | $5,493 | $289 |
| Long return visit (40+ min) | 44 | $4,700 | $104 |
| Removal of polyps or growths of large bowel using a flexible endoscope with electrical cautery | 18 | $3,300 | $183 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 33 | $2,234 | $50 |
| Incision of pancreatic outlet using a flexible endoscope | 13 | $641 | $49 |
| Diagnostic exam of lower portion of large bowel using a flexible endoscope | 15 | $553 | $37 |
2015: 21 services
| Short return visit (20+ min) | 716 | $70,698 | $53 |
| Return visit (30+ min) | 386 | $40,473 | $81 |
| New patient visit (45+ min) | 305 | $36,902 | $121 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 267 | $31,449 | $113 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 131 | $22,923 | $155 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 84 | $20,784 | $245 |
| Diagnostic exam of large bowel using a flexible endoscope | 116 | $19,964 | $172 |
| Biopsy of large bowel using a flexible endoscope | 71 | $14,674 | $207 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 62 | $10,898 | $176 |
| New patient visit (30+ min) | 130 | $9,626 | $74 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 44 | $9,376 | $213 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 57 | $9,067 | $131 |
| Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | 20 | $6,583 | $299 |
| Tying of dilated veins of stomach and/or esophagus using a flexible endoscope | 18 | $5,062 | $211 |
| Long return visit (40+ min) | 40 | $4,490 | $112 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 39 | $4,423 | $103 |
| Insertion of stomach tube using a flexible endoscope | 20 | $3,601 | $171 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 15 | $3,222 | $215 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 21 | $2,500 | $119 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 31 | $2,331 | $58 |
| Incision of pancreatic outlet using a flexible endoscope | 20 | $911 | $41 |
2014: 23 services
| Short return visit (20+ min) | 720 | $74,336 | $55 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 313 | $38,353 | $111 |
| Return visit (30+ min) | 338 | $37,488 | $83 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 206 | $36,341 | $154 |
| New patient visit (45+ min) | 271 | $32,303 | $119 |
| Diagnostic exam of large bowel using a flexible endoscope | 121 | $21,057 | $174 |
| Biopsy of large bowel using a flexible endoscope | 94 | $19,482 | $207 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 70 | $17,759 | $247 |
| New patient visit (30+ min) | 130 | $10,542 | $81 |
| Removal of polyps or growths of large bowel using a flexible endoscope with electrical cautery | 32 | $6,993 | $219 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 46 | $6,718 | $132 |
| Insertion of stomach tube using a flexible endoscope | 36 | $6,669 | $171 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 29 | $6,339 | $219 |
| Removal of polyps or growths in large bowel using an endoscope | 22 | $5,975 | $272 |
| Tying of dilated veins of stomach and/or esophagus using a flexible endoscope | 22 | $5,721 | $212 |
| Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | 16 | $5,340 | $314 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 48 | $4,847 | $101 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 63 | $4,683 | $58 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 25 | $4,349 | $174 |
| Long return visit (40+ min) | 35 | $3,640 | $104 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 13 | $2,187 | $168 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 18 | $2,107 | $117 |
| Incision of pancreatic outlet using a flexible endoscope | 15 | $722 | $48 |
2013: 25 services
| Short return visit (20+ min) | 758 | $76,208 | $55 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 325 | $44,751 | $130 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 240 | $40,434 | $151 |
| Return visit (30+ min) | 340 | $38,194 | $82 |
| New patient visit (45+ min) | 266 | $31,028 | $117 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 99 | $24,056 | $241 |
| Diagnostic exam of large bowel using a flexible endoscope | 107 | $18,300 | $169 |
| New patient visit (30+ min) | 222 | $16,918 | $76 |
| Biopsy of large bowel using a flexible endoscope | 82 | $16,413 | $198 |
| Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | 34 | $15,033 | $396 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 58 | $12,407 | $214 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 74 | $8,279 | $108 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 55 | $8,004 | $133 |
| Removal of polyps or growths of large bowel using a flexible endoscope with electrical cautery | 38 | $7,843 | $206 |
| Insertion of stomach tube using a flexible endoscope | 30 | $6,566 | $199 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 69 | $5,701 | $55 |
| Long return visit (40+ min) | 41 | $4,568 | $109 |
| Tying of dilated veins of stomach and/or esophagus using a flexible endoscope | 16 | $4,415 | $232 |
| Removal of polyps or growths in large bowel using an endoscope | 16 | $4,267 | $267 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 19 | $3,058 | $161 |
| Incision of pancreatic outlet using a flexible endoscope | 31 | $2,502 | $71 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 11 | $2,348 | $213 |
| Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $2,292 | $191 |
| New patient visit (60+ min) | 14 | $2,236 | $160 |
| Short return visit | 19 | $756 | $36 |
Medicaid work
$11,495 in 2024
Medicaid paid $11,495 for 5,520 billed services this clinician did in 2024, up to 272 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 1,920 | $4,715 |
| Upper gastrointestinal endoscopy with biopsy | 846 | $2,296 |
| COLONOSCOPY AND BIOPSY | 465 | $2,113 |
| New patient visit (45+ min) | 679 | $1,259 |
| DIAGNOSTIC COLONOSCOPY | 441 | $310 |
| Short return visit (20+ min) | 227 | $183 |
| COLONOSCOPY W/LESION REMOVAL | 66 | $150 |
| IP/OBS CONSLTJ NEW/EST PT LOW MDM 45 MINUTES | 24 | $125 |
| New patient visit (30+ min) | 91 | $112 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 504 | $84 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 205 | $71 |
| Upper gastrointestinal endoscopy of esophagus, stomach, and duodenum with insertion of guide wire and dilation of esophagus | 40 | $67 |
| 2024 | 5,520 | 13 | 272 | $11,495 |
| 2023 | 3,899 | 17 | 196 | $7,818 |
| 2022 | 4,070 | 22 | 151 | $22,928 |
| 2021 | 1,449 | 9 | 51 | $19,763 |
| 2020 | 505 | 5 | 40 | $8,807 |
| 2019 | 464 | 5 | 31 | $11,272 |
| 2018 | 3,524 | 14 | 112 | $36,867 |
See the largest Medicaid services in earlier years
2023
| New patient visit (45+ min) | 601 | $2,085 |
| Upper gastrointestinal endoscopy with biopsy | 339 | $1,668 |
| Diagnostic upper gastrointestinal endoscopy | 40 | $1,448 |
| Return visit (30+ min) | 1,689 | $1,290 |
| COLONOSCOPY AND BIOPSY | 133 | $544 |
| Short return visit (20+ min) | 348 | $415 |
| IP/OBS CONSLTJ NEW/EST PT LOW MDM 45 MINUTES | 40 | $189 |
| New patient visit (30+ min) | 129 | $94 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 158 | $42 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 229 | $39 |
| Liver elastography, mechanically induced shear wave (eg, vibration), without imaging, with interpretation and report | 14 | $2 |
| Service | 40 | $0 |
2022
| Upper gastrointestinal endoscopy with biopsy | 593 | $8,697 |
| Return visit (30+ min) | 1,205 | $4,338 |
| COLONOSCOPY AND BIOPSY | 160 | $2,801 |
| DIAGNOSTIC COLONOSCOPY | 133 | $2,106 |
| New patient visit (45+ min) | 175 | $1,720 |
| 1ST HOSP IP/OBS HIGH 75 | 121 | $1,533 |
| COLONOSCOPY W/LESION REMOVAL | 30 | $1,027 |
| Short return visit (20+ min) | 465 | $632 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 77 | $40 |
| Liver elastography, mechanically induced shear wave (eg, vibration), without imaging, with interpretation and report | 52 | $35 |
| Service | 310 | $0 |
| Service | 310 | $0 |
2021
| Upper gastrointestinal endoscopy with biopsy | 260 | $6,811 |
| Return visit (30+ min) | 427 | $5,528 |
| New patient visit (45+ min) | 171 | $5,126 |
| COLONOSCOPY AND BIOPSY | 40 | $1,195 |
| Short return visit (20+ min) | 176 | $1,104 |
| Service | 122 | $0 |
| Service | 122 | $0 |
| Service | 117 | $0 |
| DIAGNOSTIC COLONOSCOPY | 14 | $0 |
2020
| Return visit (30+ min) | 243 | $4,715 |
| Upper gastrointestinal endoscopy with biopsy | 46 | $1,834 |
| Short return visit (20+ min) | 132 | $980 |
| New patient visit (45+ min) | 60 | $847 |
| New patient visit (30+ min) | 24 | $430 |
2019
| Upper gastrointestinal endoscopy with biopsy | 154 | $6,044 |
| Return visit (30+ min) | 195 | $3,658 |
| New patient visit (45+ min) | 14 | $992 |
| Short return visit (20+ min) | 86 | $578 |
| Advance care planning including the explanation and discussion of advance directives such as standard forms (with completion of such forms, when performed), by the physician or other qualified health care professional; first 30 minutes, face-to-face with the patient, family member(s), and/or surrogate | 15 | $0 |
2018
| Upper gastrointestinal endoscopy with biopsy | 467 | $11,830 |
| DIAGNOSTIC COLONOSCOPY | 204 | $11,142 |
| COLONOSCOPY AND BIOPSY | 98 | $4,179 |
| Return visit (30+ min) | 957 | $4,046 |
| New patient visit (45+ min) | 454 | $2,773 |
| Short return visit (20+ min) | 770 | $1,674 |
| Colonoscopy, flexible; with ablation of tumor(s), polyp(s), or other lesion(s) (includes pre- and post-dilation and guide wire passage, when performed) | 27 | $397 |
| COLONOSCOPY W/LESION REMOVAL | 26 | $342 |
| 1ST HOSP IP/OBS HIGH 75 | 15 | $281 |
| New patient visit (30+ min) | 57 | $202 |
| Discharge medications reconciled with the current medication list in outpatient medical record (COA) (GER) | 206 | $0 |
| Esophagogastroduodenoscopy, flexible, transoral; with transendoscopic balloon dilation of esophagus (less than 30 mm diameter) | 14 | $0 |
Drugs they prescribed that Part D paid
$648,499
Pharmacies billed $648,499 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,810) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
1,612 generic and 198 brand-name prescriptions · $648,499 in drug cost · 81 antibiotic prescriptions to 47 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Iqirvo | 13 | $194,679 | $14,975 |
| Zeposia | 14 | $117,115 | $8,365 |
| Zenpep | 14 | $60,804 | $4,343 |
| Linzess | 56 | $41,112 | $734 |
| Voquezna | 17 | $11,864 | $698 |
See all 23 drugs
| Iqirvo | 13 | $194,679 | $14,975 |
| Zeposia | 14 | $117,115 | $8,365 |
| Zenpep | 14 | $60,804 | $4,343 |
| Linzess | 56 | $41,112 | $734 |
| Voquezna | 17 | $11,864 | $698 |
| Trulance | 13 | $11,325 | $871 |
| Dexlansoprazole Dr | 31 | $9,753 | $315 |
| Mesalamine | 32 | $8,809 | $275 |
| Gavilyte-C | 395 | $6,404 | $16 |
| Pantoprazole | 314 | $2,864 | $9 |
| Sucralfate | 38 | $2,082 | $55 |
| Famotidine | 163 | $1,785 | $11 |
| Omeprazole | 216 | $1,691 | $8 |
| Dicyclomine | 72 | $1,268 | $18 |
| Esomeprazole Magnesium | 19 | $812 | $43 |
| Peg 3350-Electrolyte | 27 | $536 | $20 |
| Clarithromycin | 19 | $462 | $24 |
| Lansoprazole | 27 | $409 | $15 |
| Ondansetron | 16 | $239 | $15 |
| Metoclopramide | 70 | $235 | $3 |
| Loperamide | 13 | $235 | $18 |
| Gavilyte-G | 17 | $215 | $13 |
| Amoxicillin | 27 | $157 | $6 |
Year by year
| 2024 | 1,810 | 735 | 0% (0) | 11% | $648,499 |
| 2023 | 1,622 | 794 | 0% (0) | 10% | $346,990 |
| 2022 | 1,288 | 637 | 0% (0) | 20% | $250,902 |
| 2021 | 1,394 | 548 | None | 24% | $406,440 |
| 2020 | 1,864 | 715 | 0% (0) | 25% | $639,525 |
| 2019 | 2,061 | 743 | 0% (0) | 19% | $530,586 |
| 2018 | 2,050 | 721 | None | None | $749,440 |
| 2017 | 1,888 | 624 | None | 22% | $484,193 |
| 2016 | 1,698 | 554 | None | 24% | $667,511 |
| 2015 | 1,723 | 545 | None | 27% | $547,152 |
| 2014 | 1,535 | 501 | 0% (0) | None | $142,499 |
| 2013 | 1,693 | 532 | None | None | $138,374 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 20 drugs
| Zeposia | 13 | $124,835 | $9,603 |
| Creon | 12 | $26,537 | $2,211 |
| Linzess | 27 | $20,512 | $760 |
| Mesalamine | 43 | $14,389 | $335 |
| Trulance | 13 | $7,440 | $572 |
| Gavilyte-C | 403 | $7,358 | $18 |
| Dexlansoprazole Dr | 22 | $6,829 | $310 |
| Pantoprazole | 278 | $5,175 | $19 |
| Omeprazole | 170 | $3,886 | $23 |
| Famotidine | 102 | $3,052 | $30 |
| Peg 3350-Electrolyte | 92 | $2,331 | $25 |
| Clarithromycin | 24 | $1,432 | $60 |
| Dicyclomine | 65 | $1,417 | $22 |
| Sucralfate | 33 | $1,089 | $33 |
| Esomeprazole Magnesium | 25 | $991 | $40 |
| Lansoprazole | 16 | $905 | $57 |
| Gavilyte-G | 34 | $587 | $17 |
| Loperamide | 12 | $500 | $42 |
| Amoxicillin | 32 | $346 | $11 |
| Metoclopramide | 34 | $244 | $7 |
2022: 18 drugs
| Cimzia | 11 | $60,587 | $5,508 |
| Creon | 21 | $41,281 | $1,966 |
| Linzess | 18 | $20,267 | $1,126 |
| Trulance | 27 | $17,794 | $659 |
| Mesalamine | 25 | $10,812 | $432 |
| Pantoprazole | 233 | $3,360 | $14 |
| Peg 3350-Electrolyte | 131 | $2,863 | $22 |
| Gavilyte-G | 141 | $1,992 | $14 |
| Omeprazole | 114 | $1,788 | $16 |
| Famotidine | 89 | $1,416 | $16 |
| Lansoprazole | 12 | $1,111 | $93 |
| Gavilyte-C | 64 | $1,102 | $17 |
| Peg-3350 and Electrolytes | 81 | $1,091 | $13 |
| Dicyclomine | 45 | $856 | $19 |
| Sucralfate | 22 | $504 | $23 |
| Esomeprazole Magnesium | 19 | $406 | $21 |
| Ondansetron | 12 | $326 | $27 |
| Metoclopramide | 28 | $114 | $4 |
2021: 24 drugs
| Creon | 41 | $109,857 | $2,679 |
| Xifaxan | 15 | $47,993 | $3,200 |
| Linzess | 33 | $29,734 | $901 |
| Trulance | 31 | $27,569 | $889 |
| Vemlidy | 11 | $14,464 | $1,315 |
| Dexilant | 30 | $11,454 | $382 |
| Mesalamine Er | 18 | $9,202 | $511 |
| Mesalamine | 29 | $8,100 | $279 |
| Suprep | 43 | $4,683 | $109 |
| Sucralfate | 30 | $4,299 | $143 |
| Pantoprazole | 271 | $3,677 | $14 |
| Omeprazole | 191 | $2,706 | $14 |
| Famotidine | 146 | $2,576 | $18 |
| Esomeprazole Magnesium | 17 | $2,325 | $137 |
| Peg 3350-Electrolyte | 66 | $1,270 | $19 |
| Dicyclomine | 46 | $838 | $18 |
| Gavilyte-G | 46 | $605 | $13 |
| Peg-3350 and Electrolytes | 46 | $582 | $13 |
| Gavilyte-C | 34 | $452 | $13 |
| Prochlorperazine Maleate | 12 | $366 | $31 |
| Spironolactone | 12 | $292 | $24 |
| Metoclopramide | 23 | $138 | $6 |
| Propranolol | 11 | $101 | $9 |
| Amoxicillin | 11 | $95 | $9 |
2020: 32 drugs
| Creon | 69 | $157,149 | $2,278 |
| Xifaxan | 38 | $114,992 | $3,026 |
| Linzess | 39 | $32,015 | $821 |
| Dexilant | 53 | $25,078 | $473 |
| Budesonide Er | 11 | $24,643 | $2,240 |
| Prevacid | 13 | $17,845 | $1,373 |
| Mesalamine | 49 | $17,814 | $364 |
| Ursodiol | 38 | $9,594 | $252 |
| Motegrity | 15 | $7,650 | $510 |
| Mesalamine Er | 17 | $6,479 | $381 |
| Budesonide Ec | 18 | $5,516 | $306 |
| Amitiza | 14 | $4,206 | $300 |
| Suprep | 39 | $4,090 | $105 |
| Pantoprazole | 311 | $3,582 | $12 |
| Omeprazole | 301 | $3,100 | $10 |
| Sucralfate | 36 | $3,092 | $86 |
| Lactulose | 31 | $2,922 | $94 |
| Famotidine | 130 | $2,261 | $17 |
| Gavilyte-G | 167 | $2,188 | $13 |
| Esomeprazole Magnesium | 16 | $2,159 | $135 |
| Peg-3350 and Electrolytes | 76 | $923 | $12 |
| Dicyclomine | 34 | $591 | $17 |
| Clarithromycin | 12 | $577 | $48 |
| Constulose | 13 | $417 | $32 |
| Spironolactone | 15 | $351 | $23 |
| Prochlorperazine Maleate | 14 | $309 | $22 |
| Gavilyte-C | 16 | $207 | $13 |
| Peg 3350-Electrolyte | 12 | $198 | $17 |
| Ranitidine | 13 | $163 | $13 |
| Metoclopramide | 26 | $142 | $5 |
| Amoxicillin | 11 | $108 | $10 |
| Furosemide | 13 | $66 | $5 |
2019: 34 drugs
| Xifaxan | 67 | $188,005 | $2,806 |
| Creon | 20 | $49,518 | $2,476 |
| Zenpep | 19 | $39,859 | $2,098 |
| Prevacid | 12 | $19,718 | $1,643 |
| Dexilant | 49 | $19,567 | $399 |
| Linzess | 30 | $17,331 | $578 |
| Mesalamine | 26 | $11,158 | $429 |
| Ursodiol | 46 | $8,931 | $194 |
| Trulance | 15 | $7,132 | $475 |
| Omeprazole | 413 | $4,599 | $11 |
| Budesonide Ec | 11 | $3,721 | $338 |
| Gavilyte-G | 262 | $3,558 | $14 |
| Pantoprazole | 270 | $3,078 | $11 |
| Ranitidine | 205 | $2,247 | $11 |
| Suprep | 17 | $1,632 | $96 |
| Famotidine | 81 | $1,260 | $16 |
| Esomeprazole Magnesium | 12 | $1,085 | $90 |
| Dicyclomine | 54 | $961 | $18 |
| Lactulose | 12 | $840 | $70 |
| Sucralfate | 28 | $806 | $29 |
| Hydrocortisone | 16 | $647 | $40 |
| Peg-3350 and Electrolytes | 47 | $584 | $12 |
| Clarithromycin | 16 | $550 | $34 |
| Lansoprazole | 12 | $530 | $44 |
| Peg 3350-Electrolyte | 19 | $340 | $18 |
| Prochlorperazine Maleate | 13 | $215 | $17 |
| Spironolactone | 15 | $177 | $12 |
| Pravastatin | 11 | $169 | $15 |
| Metronidazole | 11 | $155 | $14 |
| Metoclopramide | 49 | $152 | $3 |
| Ondansetron | 11 | $150 | $14 |
| Gavilyte-C | 11 | $149 | $14 |
| Amoxicillin | 12 | $88 | $7 |
| Furosemide | 13 | $74 | $6 |
2018: 31 drugs
| Xifaxan | 42 | $99,480 | $2,369 |
| Creon | 29 | $73,781 | $2,544 |
| Trulance | 25 | $25,446 | $1,018 |
| Linzess | 43 | $22,726 | $529 |
| Dexilant | 57 | $20,459 | $359 |
| Prevacid | 13 | $19,675 | $1,513 |
| Nexium | 21 | $7,196 | $343 |
| Ursodiol | 31 | $6,168 | $199 |
| Mesalamine | 13 | $3,978 | $306 |
| Esomeprazole Magnesium | 36 | $3,927 | $109 |
| Omeprazole | 367 | $3,057 | $8 |
| Pantoprazole | 312 | $2,863 | $9 |
| Gavilyte-G | 197 | $2,815 | $14 |
| Ranitidine | 148 | $2,289 | $15 |
| Suprep | 14 | $1,234 | $88 |
| Famotidine | 88 | $1,218 | $14 |
| Peg-3350 and Electrolytes | 90 | $1,179 | $13 |
| Clarithromycin | 13 | $801 | $62 |
| Sucralfate | 28 | $746 | $27 |
| Azathioprine | 11 | $650 | $59 |
| Dicyclomine | 50 | $475 | $9 |
| Lactulose | 13 | $417 | $32 |
| Peg 3350-Electrolyte | 20 | $375 | $19 |
| Spironolactone | 18 | $298 | $17 |
| Lansoprazole | 14 | $297 | $21 |
| Propranolol | 13 | $238 | $18 |
| Metoclopramide | 52 | $217 | $4 |
| Amoxicillin | 17 | $134 | $8 |
| Lamotrigine | 17 | $100 | $6 |
| Prochlorperazine Maleate | 14 | $87 | $6 |
| Furosemide | 11 | $28 | $3 |
2017: 28 drugs
| Xifaxan | 58 | $128,958 | $2,223 |
| Uceris | 13 | $26,774 | $2,060 |
| Creon | 17 | $25,115 | $1,477 |
| Linzess | 54 | $21,282 | $394 |
| Dexilant | 54 | $18,034 | $334 |
| Lialda | 11 | $7,510 | $683 |
| Nexium | 14 | $5,186 | $370 |
| Esomeprazole Magnesium | 23 | $3,032 | $132 |
| Carafate | 11 | $3,016 | $274 |
| Omeprazole | 347 | $2,855 | $8 |
| Pantoprazole | 357 | $2,732 | $8 |
| Gavilyte-G | 181 | $2,418 | $13 |
| Ursodiol | 12 | $2,398 | $200 |
| Peg-3350 and Electrolytes | 112 | $1,445 | $13 |
| Suprep | 14 | $1,100 | $79 |
| Ranitidine | 87 | $920 | $11 |
| Proctozone-Hc | 13 | $901 | $69 |
| Famotidine | 72 | $800 | $11 |
| Sucralfate | 36 | $635 | $18 |
| Spironolactone | 23 | $470 | $20 |
| Levetiracetam | 12 | $429 | $36 |
| Dicyclomine | 55 | $381 | $7 |
| Lactulose | 12 | $323 | $27 |
| Propranolol | 21 | $316 | $15 |
| Lamotrigine | 43 | $230 | $5 |
| Metoclopramide | 27 | $136 | $5 |
| Prochlorperazine Maleate | 18 | $135 | $7 |
| Lansoprazole | 15 | $113 | $8 |
2016: 24 drugs
| Xifaxan | 44 | $83,137 | $1,889 |
| Nexium | 67 | $23,249 | $347 |
| Linzess | 42 | $15,170 | $361 |
| Dexilant | 49 | $11,894 | $243 |
| Lialda | 12 | $5,551 | $463 |
| Omeprazole | 379 | $2,888 | $8 |
| Pantoprazole | 278 | $2,273 | $8 |
| Gavilyte-G | 149 | $2,083 | $14 |
| Ranitidine | 67 | $1,497 | $22 |
| Peg-3350 and Electrolytes | 96 | $1,178 | $12 |
| Clarithromycin | 14 | $861 | $61 |
| Sucralfate | 36 | $673 | $19 |
| Dicyclomine | 59 | $433 | $7 |
| Levetiracetam | 12 | $412 | $34 |
| Famotidine | 36 | $330 | $9 |
| Prochlorperazine Maleate | 20 | $260 | $13 |
| Propranolol | 22 | $243 | $11 |
| Metoclopramide | 48 | $199 | $4 |
| Lamotrigine | 22 | $162 | $7 |
| Peg 3350-Electrolyte | 12 | $126 | $10 |
| Spironolactone | 11 | $114 | $10 |
| Amoxicillin | 12 | $100 | $8 |
| Quetiapine | 11 | $41 | $4 |
| Furosemide | 15 | $32 | $2 |
2015: 25 drugs
| Xifaxan | 27 | $45,154 | $1,672 |
| Nexium | 100 | $32,285 | $323 |
| Creon | 13 | $17,803 | $1,369 |
| Dexilant | 44 | $9,465 | $215 |
| Linzess | 19 | $7,025 | $370 |
| Amitiza | 26 | $6,630 | $255 |
| Omeprazole | 416 | $3,559 | $9 |
| Gavilyte-G | 124 | $1,728 | $14 |
| Pantoprazole | 186 | $1,597 | $9 |
| Peg-3350 and Electrolytes | 84 | $1,237 | $15 |
| Ranitidine | 75 | $1,001 | $13 |
| Propranolol | 51 | $563 | $11 |
| Dicyclomine | 70 | $557 | $8 |
| Generlac | 14 | $479 | $34 |
| Levetiracetam | 12 | $469 | $39 |
| Sucralfate | 18 | $466 | $26 |
| Metronidazole | 11 | $307 | $28 |
| Prochlorperazine Maleate | 26 | $256 | $10 |
| Spironolactone | 18 | $246 | $14 |
| Metoclopramide | 53 | $219 | $4 |
| Diphenoxylate-Atropine | 11 | $199 | $18 |
| Famotidine | 33 | $193 | $6 |
| Donepezil | 19 | $171 | $9 |
| Lamotrigine | 13 | $144 | $11 |
| Furosemide | 33 | $75 | $2 |
2014: 29 drugs
| Xifaxan | 22 | $31,356 | $1,425 |
| Nexium | 101 | $30,724 | $304 |
| Dexilant | 56 | $10,579 | $189 |
| Creon | 15 | $10,058 | $671 |
| Lialda | 11 | $8,179 | $744 |
| Amitiza | 20 | $7,181 | $359 |
| Linzess | 20 | $5,455 | $273 |
| Omeprazole | 376 | $3,940 | $10 |
| Peg-3350 and Electrolytes | 111 | $1,693 | $15 |
| Pantoprazole | 135 | $1,219 | $9 |
| Gavilyte-G | 64 | $959 | $15 |
| Ranitidine | 56 | $721 | $13 |
| Lactulose | 21 | $670 | $32 |
| Sucralfate | 25 | $670 | $27 |
| Levetiracetam | 11 | $643 | $58 |
| Spironolactone | 23 | $559 | $24 |
| Lansoprazole | 14 | $537 | $38 |
| Dicyclomine | 57 | $377 | $7 |
| Carbidopa-Levodopa | 11 | $350 | $32 |
| Lamotrigine | 14 | $265 | $19 |
| Metoclopramide | 37 | $210 | $6 |
| Peg 3350-Electrolyte | 18 | $206 | $11 |
| Mirtazapine | 17 | $176 | $10 |
| Famotidine | 28 | $166 | $6 |
| Propranolol | 30 | $148 | $5 |
| Carbidopa-Levodopa Er | 11 | $146 | $13 |
| Prochlorperazine Maleate | 16 | $140 | $9 |
| Furosemide | 31 | $115 | $4 |
| Amoxicillin | 15 | $102 | $7 |
2013: 21 drugs
| Nexium | 154 | $39,216 | $255 |
| Xifaxan | 21 | $27,599 | $1,314 |
| Dexilant | 58 | $11,369 | $196 |
| Omeprazole | 476 | $6,806 | $14 |
| Amitiza | 17 | $4,663 | $274 |
| Linzess | 15 | $3,245 | $216 |
| Pantoprazole | 154 | $2,403 | $16 |
| Peg-3350 and Electrolytes | 116 | $1,939 | $17 |
| Clarithromycin | 11 | $1,095 | $100 |
| Ranitidine | 70 | $577 | $8 |
| Dicyclomine | 60 | $415 | $7 |
| Sucralfate | 14 | $408 | $29 |
| Gavilyte-G | 24 | $364 | $15 |
| Metoclopramide | 54 | $309 | $6 |
| Peg-3350 With Flavor Packs | 12 | $287 | $24 |
| Peg 3350-Electrolyte | 21 | $249 | $12 |
| Spironolactone | 18 | $245 | $14 |
| Prochlorperazine Maleate | 15 | $224 | $15 |
| Propranolol | 37 | $209 | $6 |
| Famotidine | 28 | $202 | $7 |
| Furosemide | 34 | $187 | $6 |
Money from drug and device companies
$2,004 in 2025
| 2025 | 15 | 101 | None | $2,004 |
| 2024 | 17 | 61 | None | $1,364 |
| 2023 | 19 | 85 | None | $1,688 |
| 2022 | 14 | 92 | None | $1,688 |
| 2021 | 9 | 41 | None | $789 |
| 2020 | 7 | 16 | None | $394 |
| 2019 | 10 | 28 | None | $653 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Linzess | $688 | 44 payments
|
| Aimmune Therapeutics | Vowst | $266 | 23 payments
|
| Ipsen Biopharmaceuticals | Iqirvo | $260 | 7 payments
|
| Madrigal Pharmaceuticals | Rezdiffra | $155 | 8 payments
|
| Janssen Biotech | Tremfya | $146 | 1 payment
|
| Genzyme | Dupixent | $110 | 3 payments
|
See all 101 published payments
| Aimmune Therapeutics | Meals · 2025-12-30 | Vowst | $19 |
| Ipsen Biopharmaceuticals | Meals · 2025-12-22 | Iqirvo | $15 |
| Abbvie | Meals · 2025-12-16 | Linzess | $13 |
| Abbvie | Meals · 2025-12-11 | Rinvoq | $18 |
| Abbvie | Meals · 2025-12-08 | Creon | $10 |
| Ipsen Biopharmaceuticals | Meals · 2025-12-08 | Iqirvo | $23 |
| Aimmune Therapeutics | Meals · 2025-11-26 | Vowst | $22 |
| Abbvie | Meals · 2025-11-25 | Rinvoq | $16 |
| Genzyme | Meals · 2025-11-19 | Dupixent | $40 |
| Abbvie | Meals · 2025-11-18 | Linzess | $19 |
| Abbvie | Meals · 2025-11-05 | Creon | $21 |
| Abbvie | Meals · 2025-11-04 | Skyrizi | $23 |
| Abbvie | Meals · 2025-11-04 | Linzess | $11 |
| Ipsen Biopharmaceuticals | Meals · 2025-10-22 | Iqirvo | $25 |
| Abbvie | Meals · 2025-10-16 | Linzess | $23 |
| Aimmune Therapeutics | Meals · 2025-10-16 | Vowst | $22 |
| Abbvie | Meals · 2025-10-15 | Rinvoq | $21 |
| Abbvie | Meals · 2025-10-15 | Creon | $33 |
| Phathom Pharmaceuticals | Meals · 2025-10-15 | Voquezna | $11 |
| Ardelyx | Meals · 2025-10-13 | Ibsrela | $21 |
| Madrigal Pharmaceuticals | Meals · 2025-10-09 | Rezdiffra | $27 |
| Madrigal Pharmaceuticals | Meals · 2025-10-02 | Rezdiffra | $23 |
| Abbvie | Meals · 2025-09-24 | Linzess | $15 |
| Abbvie | Meals · 2025-09-24 | Creon | $0 |
| Genzyme | Meals · 2025-09-18 | Dupixent | $40 |
| Abbvie | Meals · 2025-09-17 | Rinvoq | $6 |
| Aimmune Therapeutics | Meals · 2025-09-17 | Vowst | $19 |
| Cook Medical | Meals · 2025-09-16 | Echotip Insight | $97 |
| Ipsen Biopharmaceuticals | Meals · 2025-09-11 | Iqirvo | $122 |
| Abbvie | Meals · 2025-09-10 | Linzess | $34 |
| Ipsen Biopharmaceuticals | Meals · 2025-09-09 | Iqirvo | $28 |
| Abbvie | Meals · 2025-09-08 | Linzess | $17 |
| Aimmune Therapeutics | Meals · 2025-09-03 | Vowst | $15 |
| Regeneron Healthcare Solutions | Meals · 2025-08-28 | Dupixent | $16 |
| Madrigal Pharmaceuticals | Meals · 2025-08-20 | Rezdiffra | $30 |
| Aimmune Therapeutics | Meals · 2025-08-15 | Vowst | $11 |
| Aimmune Therapeutics | Meals · 2025-08-07 | Vowst | $16 |
| Ipsen Biopharmaceuticals | Meals · 2025-08-06 | Iqirvo | $27 |
| Abbvie | Meals · 2025-08-05 | Mavyret | $9 |
| Abbvie | Meals · 2025-07-30 | Linzess | $10 |
| Abbvie | Meals · 2025-07-30 | Rinvoq | $21 |
| Lilly USA | Meals · 2025-07-24 | Omvoh | $22 |
| Abbvie | Meals · 2025-07-23 | Linzess | $5 |
| Abbvie | Meals · 2025-07-23 | Rinvoq | $11 |
| Abbvie | Meals · 2025-07-23 | Linzess | $13 |
| Aimmune Therapeutics | Meals · 2025-07-22 | Vowst | $5 |
| Abbvie | Meals · 2025-07-02 | Mavyret | $14 |
| Abbvie | Meals · 2025-07-01 | Rinvoq | $12 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-06-30 | Xifaxan | $21 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-06-30 | Xifaxan | $15 |
| Aimmune Therapeutics | Meals · 2025-06-27 | Vowst | $14 |
| Abbvie | Meals · 2025-06-26 | Linzess | $10 |
| Aimmune Therapeutics | Meals · 2025-06-19 | Vowst | $4 |
| Abbvie | Meals · 2025-06-18 | Linzess | $23 |
| Madrigal Pharmaceuticals | Meals · 2025-06-17 | Rezdiffra | $5 |
| Abbvie | Meals · 2025-06-12 | Linzess | $6 |
| Abbvie | Meals · 2025-06-11 | Rinvoq | $18 |
| Aimmune Therapeutics | Meals · 2025-06-10 | Vowst | $16 |
| Ipsen Biopharmaceuticals | Meals · 2025-06-03 | Iqirvo | $21 |
| Abbvie | Meals · 2025-05-28 | Rinvoq | $10 |
| Abbvie | Meals · 2025-05-27 | Mavyret | $24 |
| Aimmune Therapeutics | Meals · 2025-05-21 | Vowst | $14 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-05-19 | Xifaxan | $23 |
| Abbvie | Meals · 2025-05-15 | Linzess | $10 |
| Madrigal Pharmaceuticals | Meals · 2025-05-15 | Rezdiffra | $24 |
| Aimmune Therapeutics | Meals · 2025-05-13 | Vowst | $10 |
| Aimmune Therapeutics | Meals · 2025-05-05 | Vowst | $6 |
| Aimmune Therapeutics | Meals · 2025-05-01 | Vowst | $6 |
| Abbvie | Meals · 2025-04-30 | Rinvoq | $21 |
| Abbvie | Meals · 2025-04-30 | Linzess | $7 |
| Abbvie | Meals · 2025-04-29 | Rinvoq | $20 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-04-28 | Xifaxan | $25 |
| Abbvie | Meals · 2025-04-21 | Mavyret | $12 |
| Abbvie | Meals · 2025-04-16 | Skyrizi | $7 |
| Abbvie | Meals · 2025-04-09 | Linzess | $23 |
| Madrigal Pharmaceuticals | Meals · 2025-04-09 | Rezdiffra | $27 |
| Janssen Biotech | Meals · 2025-04-08 | Tremfya | $146 |
| Madrigal Pharmaceuticals | Meals · 2025-04-07 | Rezdiffra | $8 |
| Gilead Sciences | Meals · 2025-03-25 | None | $27 |
| Aimmune Therapeutics | Meals · 2025-03-25 | Vowst | $5 |
| Abbvie | Meals · 2025-03-19 | Linzess | $5 |
| Aimmune Therapeutics | Meals · 2025-03-06 | Vowst | $6 |
| Phathom Pharmaceuticals | Meals · 2025-03-03 | Voquezna | $13 |
| Abbvie | Meals · 2025-02-26 | Creon | $23 |
| Regeneron Healthcare Solutions | Meals · 2025-02-24 | Dupixent | $34 |
| Pfizer | Meals · 2025-02-20 | Xeljanz | $15 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-02-19 | Relistor | $21 |
| Genzyme | Meals · 2025-02-19 | Dupixent | $30 |
| Abbvie | Meals · 2025-02-18 | Linzess | $29 |
| Aimmune Therapeutics | Meals · 2025-02-18 | Vowst | $8 |
| Aimmune Therapeutics | Meals · 2025-02-13 | Vowst | $4 |
| Aimmune Therapeutics | Meals · 2025-02-12 | Vowst | $10 |
| Abbvie | Meals · 2025-02-04 | Linzess | $20 |
| Aimmune Therapeutics | Meals · 2025-02-04 | Vowst | $6 |
| Madrigal Pharmaceuticals | Meals · 2025-01-29 | Rezdiffra | $11 |
| Abbvie | Meals · 2025-01-22 | Linzess | $22 |
| Aimmune Therapeutics | Meals · 2025-01-22 | Vowst | $15 |
| Abbvie | Meals · 2025-01-17 | Creon | $4 |
| Aimmune Therapeutics | Meals · 2025-01-14 | Vowst | $11 |
| Ironwood Pharmaceuticals | Meals · 2025-01-13 | Linzess | $17 |
| Abbvie | Meals · 2025-01-08 | Skyrizi | $20 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,364
| Abbvie | Linzess | $515 | 31 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $177 | 5 payments
|
| Gilead Sciences | Vemlidy | $133 | 2 payments
|
| Ipsen Biopharmaceuticals | Bylvay | $122 | 1 payment
|
| Pfizer | Xeljanz | $100 | 5 payments
|
| Aimmune Therapeutics | Vowst | $46 | 3 payments
|
| Genzyme | Dupixent | $37 | 2 payments
|
| Madrigal Pharmaceuticals | Resmetirom | $35 | 2 payments
|
| QOL Medical | Sucraid | $31 | 1 payment
|
| Mirum Pharmaceuticals | Livmarli | $29 | 1 payment
|
| Lilly USA | Omvoh | $28 | 1 payment
|
| Phathom Pharmaceuticals | Voquezna | $28 | 2 payments
|
| Merck Sharp & Dohme | Dificid | $20 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $18 | 1 payment
|
| Ironwood Pharmaceuticals | Linzess | $17 | 1 payment
|
| Intercept Pharmaceuticals | Ocaliva | $15 | 1 payment
|
| Celgene | Zeposia | $14 | 1 payment
|
2023: $1,688
| Celgene | Zeposia | $452 | 32 payments
|
| AbbVie | Viberzi | $356 | 26 payments
|
| Gilead Sciences | Vemlidy | $225 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $110 | 1 payment
|
| Pfizer | Xeljanz | $84 | 4 payments
|
| Janssen Biotech | Stelara | $54 | 2 payments
|
| Regeneron Healthcare Solutions | Dupixent | $48 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $48 | 2 payments
|
| Boston Scientific | Exalt Model D | $47 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $41 | 2 payments
|
| Olympus America | Evis Exera III Xenon Light Source | $39 | 1 payment
|
| Ardelyx | Ibsrela | $32 | 2 payments
|
| Nestle Healthcare Nutrition | Zenpep | $30 | 2 payments
|
| Genzyme | Dupixent | $27 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Cyltezo | $25 | 1 payment
|
| QOL Medical | Sucraid | $24 | 1 payment
|
| Phathom Pharmaceuticals | Voquezna | $18 | 1 payment
|
| Celltrion USA | Yuflyma | $17 | 1 payment
|
| Vivus | Pancreaze | $13 | 1 payment
|
2022: $1,688
| Celgene | Zeposia | $498 | 31 payments
|
| Abbvie | Linzess | $331 | 27 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $301 | 14 payments
|
| Novo Nordisk | None | $125 | 1 payment
|
| Regeneron Pharmaceuticals | None | $107 | 1 payment
|
| Janssen Biotech | Stelara | $86 | 4 payments
|
| Regeneron Healthcare Solutions | Dupixent | $75 | 4 payments
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $56 | 3 payments
|
| Nestle HealthCare Nutrition | Zenpep | $28 | 2 payments
|
| Gilead Sciences | None | $27 | 1 payment
|
| Intercept Pharmaceuticals | Ocaliva | $18 | 1 payment
|
| Genzyme | Dupixent | $13 | 1 payment
|
| Boston Scientific | Exalt Model D | $12 | 1 payment
|
| Ironwood Pharmaceuticals | Linzess | $12 | 1 payment
|
2021: $789
| AbbVie | Mavyret | $386 | 26 payments
|
| E.R. Squibb & Sons L.L.C. | Zeposia | $121 | 1 payment
|
| Janssen Biotech | Stelara | $103 | 4 payments
|
| Gilead Sciences | None | $57 | 3 payments
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $54 | 3 payments
|
| Nestle HealthCare Nutrition | Zenpep | $21 | 1 payment
|
| Pfizer | Xeljanz | $16 | 1 payment
|
| Boston Scientific | Exalt | $15 | 1 payment
|
| Vivus | Pancreaze | $15 | 1 payment
|
2020: $394
| AbbVie | Humira | $128 | 8 payments
|
| Intercept Pharmaceuticals | None | $121 | 1 payment
|
| Janssen Biotech | Stelara | $60 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $34 | 2 payments
|
| Alfasigma USA | Zelnorm | $19 | 1 payment
|
| Pfizer | Xeljanz | $18 | 1 payment
|
| Shionogi | Mulpleta | $15 | 1 payment
|
2019: $653
| Gilead Sciences | Epclusa | $232 | 3 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $146 | 12 payments
|
| Jazz Pharmaceuticals | Xyrem | $100 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $59 | 6 payments
|
| Vivus | Pancreaze | $27 | 1 payment
|
| Boston Scientific | Orise | $23 | 1 payment
|
| AbbVie | Mavyret | $23 | 1 payment
|
| Pfizer | Xeljanz | $17 | 1 payment
|
| Ironwood Pharmaceuticals | Linzess | $14 | 1 payment
|
| Allergan | Zenpep | $13 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 85.8 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1831291863
- Licence
- CA A450510
- Group
- Community Foundation Medical Group · Central California Faculty Medical Group Inc · Camarena Health
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A450510
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X)
- Mailing address
- 451 E Almond Ave, Suite # 103, Madera, CA, 93637
- NPI first listed
- 2006-09-01
- NPI last updated
- 2021-01-27
- NPI record certified
- 2021-01-27
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2823 Fresno St, Fresno, CA, 93721